Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zbyněk Nový

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modificationsKatarína Hajduová, Kateřina Dvořáková Bendová, Miloš Petřík, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 13, 2014
Chelating polymeric beads as potential therapeutics for Wilson's diseaseJana Mattová, Pavla Poučková, Jan Kučka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2025
Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical studyGiacomo Gariglio, Thomas Hasenöhrl, Katerina Bendova, et al.
EJNMMI Radiopharmacy and Chemistry|April 4, 2025
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with <sup>225</sup>AcKateřina Ondrák Fialová, Lukáš Ondrák, Martin Vlk, et al.
Journal of Medicinal Chemistry|December 3, 2020
Iodinated Choline Transport-Targeted TracersPavel Švec, Zbyněk Nový, Jan Kučka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expressionKateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová, et al.
Molecular Pharmaceutics|March 3, 2026
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast CancerHarun Taş, Martin Schäfer, Aneeba Shuja-Uddin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modificationsKatarína Hajduová, Kateřina Dvořáková Bendová, Miloš Petřík, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 13, 2014
Chelating polymeric beads as potential therapeutics for Wilson's diseaseJana Mattová, Pavla Poučková, Jan Kučka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2025
Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical studyGiacomo Gariglio, Thomas Hasenöhrl, Katerina Bendova, et al.
EJNMMI Radiopharmacy and Chemistry|April 4, 2025
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with <sup>225</sup>AcKateřina Ondrák Fialová, Lukáš Ondrák, Martin Vlk, et al.
Journal of Medicinal Chemistry|December 3, 2020
Iodinated Choline Transport-Targeted TracersPavel Švec, Zbyněk Nový, Jan Kučka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expressionKateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová, et al.
Molecular Pharmaceutics|March 3, 2026
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast CancerHarun Taş, Martin Schäfer, Aneeba Shuja-Uddin, et al.
Pageof 1